IBIO is one of those stocks that does not look that great on the historical charts, but it does look great on paper. Based on what can be found online, they appear to have tons of value and the potential to boom in the upcoming years due to their concept of FastPharming. I look forward to seeing what they have in store for the future with their pending product patent applications for:
Antibodies
Influenza Vaccines
Influenza Therapeutic Antibodies
Anthrax Vaccines
Plague Vaccines
HPV Vaccines
Trypanosomiasis Vaccine
Malaria Vaccines
Endostatin fragments & variants for treating fibrosis
COVID-19 Vaccines
Antibodies
Influenza Vaccines
Influenza Therapeutic Antibodies
Anthrax Vaccines
Plague Vaccines
HPV Vaccines
Trypanosomiasis Vaccine
Malaria Vaccines
Endostatin fragments & variants for treating fibrosis
COVID-19 Vaccines